HIMS & HERS Trademark

Trademark Overview


On Friday, August 21, 2020, a trademark application was filed for HIMS & HERS with the United States Patent and Trademark Office. The USPTO has given the HIMS & HERS trademark a serial number of 90130458. The federal status of this trademark filing is REQUEST FOR FIFTH EXTENSION - FILED as of Friday, April 19, 2024. This trademark is owned by Hims, Inc.. The HIMS & HERS trademark is filed in the Pharmaceutical Products category with the following description:

Medicated hair care preparations; pharmaceutical preparations used to treat eyelashes; pharmaceutical preparations for the treatment of hair loss; medicated dandruff shampoo; pharmaceutical preparations for the treatment of hirsutism and to retard hair growth; pharmaceutical preparations for the treatment of erectile dysfunction; pharmaceutical preparations for the treatment of premature ejaculation; vitamins; prenatal vitamins; medicated skin care preparations; medicated mouth care and treatment preparations; cold sore treatment preparations; dietary and nutritional supplements, namely, dehydroepiandrosterone (DHEA) supplements; dietary and nutritional supplements, namely, weight loss and weight management supplements; dietary and nutritional supplements, namely, nootropics; dietary and nutritional supplements, namely, energy supplements; dietary and nutritional supplements, namely, testosterone supplements; medical diagnostic test kits consisting of reagents and assays for testing th...
hims & hers

General Information


Serial Number90130458
Word MarkHIMS & HERS
Filing DateFriday, August 21, 2020
Status722 - REQUEST FOR FIFTH EXTENSION - FILED
Status DateFriday, April 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 24, 2021

Trademark Statements


Goods and ServicesMedicated hair care preparations; pharmaceutical preparations used to treat eyelashes; pharmaceutical preparations for the treatment of hair loss; medicated dandruff shampoo; pharmaceutical preparations for the treatment of hirsutism and to retard hair growth; pharmaceutical preparations for the treatment of erectile dysfunction; pharmaceutical preparations for the treatment of premature ejaculation; vitamins; prenatal vitamins; medicated skin care preparations; medicated mouth care and treatment preparations; cold sore treatment preparations; dietary and nutritional supplements, namely, dehydroepiandrosterone (DHEA) supplements; dietary and nutritional supplements, namely, weight loss and weight management supplements; dietary and nutritional supplements, namely, nootropics; dietary and nutritional supplements, namely, energy supplements; dietary and nutritional supplements, namely, testosterone supplements; medical diagnostic test kits consisting of reagents and assays for testing the presence of pregnancy, STDs, AMH, diabetes, hyperhidrosis; pharmaceutical preparations for treating psoriasis and eczema; medicated acne treatment preparations; pharmaceutical preparations, namely, smoking cessation preparations; pharmaceutical preparations for birth control; fertility enhancement preparations; menopause treatment preparations; menstrual symptom treatment preparations; hormone replacement preparations and substances; estrogen preparations; transdermal patches featuring vitamins; pharmaceutical and medicinal preparations for use in the treatment of herpes, vulvar and vaginal atrophy, sleep disorders, acid reflux, allergies, depression, cardiovascular disorders and cholesterol reduction; medicinal preparations for treating anxiety; antifungal preparations; medicinal preparations used as narcotic antagonists; personal lubricants; vaginal moisturizers; sexual arousal and sexual stimulant preparations; sexual care products, namely, oral vitamin supplements; pain relief medication; analgesic preparations; analgesics, namely, naproxen sodium, ibuprofen, and acetaminophen; medical diagnostic test kits for testing the presence of medical conditions, namely, SARS-CoV-2 coronavirus
Pseudo MarkHIMS AND HERS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 24, 2020
Primary Code005
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History


Party NameHims, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, US 94123

Party NameHims, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, US 94123

Trademark Events


Event DateEvent Description
Tuesday, August 25, 2020NEW APPLICATION ENTERED
Thursday, September 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 17, 2020ASSIGNED TO EXAMINER
Friday, December 18, 2020ASSIGNED TO EXAMINER
Friday, January 29, 2021ASSIGNED TO EXAMINER
Friday, February 5, 2021NON-FINAL ACTION WRITTEN
Friday, February 5, 2021NON-FINAL ACTION E-MAILED
Friday, February 5, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 29, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 29, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 30, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 22, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 4, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 24, 2021PUBLISHED FOR OPPOSITION
Tuesday, August 24, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 19, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 11, 2022SOU TEAS EXTENSION RECEIVED
Monday, April 11, 2022SOU EXTENSION 1 FILED
Monday, April 11, 2022SOU EXTENSION 1 GRANTED
Wednesday, April 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 19, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, October 19, 2022SOU EXTENSION 2 FILED
Wednesday, October 19, 2022SOU EXTENSION 2 GRANTED
Friday, October 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 12, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, April 12, 2023SOU EXTENSION 3 FILED
Wednesday, April 12, 2023SOU EXTENSION 3 GRANTED
Friday, April 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 19, 2023TEAS REQUEST TO DIVIDE RECEIVED
Thursday, October 19, 2023DIVISIONAL REQUEST RECEIVED
Thursday, October 19, 2023SOU EXTENSION 4 FILED
Thursday, October 19, 2023SOU TEAS EXTENSION RECEIVED
Friday, October 27, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 27, 2023DIVISIONAL PROCESSING COMPLETE
Friday, October 27, 2023SOU EXTENSION 4 GRANTED
Saturday, October 28, 2023CORRECTED NOA E-MAILED
Saturday, October 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 19, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 19, 2024SOU EXTENSION 5 FILED
Friday, April 19, 2024SOU EXTENSION 5 GRANTED
Saturday, April 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED